Biomedical Device Consultants and Laboratories of Colorado, LLC v. Vivitro Labs, Inc. (Fed. Cir. 2024)

A preliminary injunction is one of the most potent weapons in a patent plaintiff’s arsenal, being capable of shutting down an accused infringer’s continued infringement, prohibiting the infringing product from the stream of commerce, and forcing (or at least strongly motivating) a defendant to settlement.  Being so powerful, such injunctions are not easily obtained and are cabined by several requirements, the most potent being the need to show a likelihood of success on the merits at trial….
By: McDonnell Boehnen Hulbert & Berghoff LLP
Previous Story

Weekly Blockchain Blog – April 2024 #2

Next Story

Unlocking Digital Infrastructure: European Market Drivers and Trends